At what enterprise value was WINBACK acquired in 2025?

During the acquisition of WINBACK by CHARTERHOUSE in 2025, the company was valued at an estimated revenue multiple of below 5x. The transaction's Enterprise Value is estimated to be in the range of 100M - 350M EUR. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Healthcare & Pharma industry currently tracks an average EBITDA multiple of 15.6x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of WINBACK when it was acquired by CHARTERHOUSE?

The estimated EV/EBITDA multiple for WINBACK is in the range of 10x - 18x. For comparison, the Healthcare & Pharma sector currently shows an average EBITDA multiple of 15.6x. Join our community for free to access full valuation data and industry trends.

When was WINBACK acquired by CHARTERHOUSE?

WINBACK was acquired by CHARTERHOUSE in 2025.

What was the revenue of WINBACK at the time of the deal?

The revenue of WINBACK at the time of the deal is estimated to be in the range of 25M - 50M EUR. Register for free to access the full transaction report and exact valuation multiples.

What was the EBITDA of WINBACK during the acquisition?

WINBACK's EBITDA is estimated to be in the range of 5M - 25M EUR. Join our community for free to access complete and exact deal data.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the WINBACK acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the WINBACK deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://capitalfinance.lesechos.fr/deals/lbo/charterhouse-valorise-winback-13-fois-son-ebitda-2202529

← DATABASE

Home Database Healthcare & PharmaWINBACK

12/2025

WINBACK acquired by CHARTERHOUSE

FRANCE Life Sciences / Medical Devices EV 100M - 350M EUR

Context

Charterhouse Capital Partners acquired a majority equity stake in Winback following a competitive process that attracted interest from several top-tier private equity funds. This transaction facilitates the exit of Capza, which had supported the company since late 2021 through a minority "flex equity" structure, and allows the founding duo to cash out a portion of their holdings while reinvesting to remain significant minority shareholders and operational leaders. The deal is financed through a combination of equity and a debt package comprising senior bank debt provided by a consortium of French banks and a mezzanine tranche arranged by a specialized private debt fund. The new partnership is intended to drive the next phase of growth, focusing on deepening market penetration in existing territories and expanding the product portfolio.

WINBACK, which reported an EBITDA margin of in 2024, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (15.6x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Founded in 2013, Winback is a high-growth French medical technology company specializing in the design, manufacturing, and distribution of advanced devices for tissue rehabilitation and pain management. The company has built its reputation on TECAR technology (Transfer of Energy Capacitive and Resistive), utilizing high-frequency currents to accelerate the body's natural regeneration processes. Beyond its core radiofrequency solutions, Winback has diversified its portfolio to include cryotherapy and compression systems. Its devices are essential tools for a wide range of practitioners, including physiotherapists, osteopaths, and sports doctors, with applications extending to chronic pain treatment, women's post-partum health, and aesthetic medicine.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2024

2023

Similar deals in Life Sciences

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
01/2026	FAGRON	UNIVERSITY COMPOUNDING PHARMACY (UCP)	UNITED STATES	Compounding
01/2026	YOTTA CAPITAL	VILLARD	FRANCE	Medical Consumables
11/2025	ARLANE	DESSINTEY	FRANCE	Medical Devices
11/2025	PFIZER	METSERA	UNITED STATES	R&D Biotech
11/2025	ANJAC BEAUTY & HEALTH	HEALTH CHAIN GROUP (HCG)	SLOVENIA	CDMO
10/2025	PUBLIC MARKETS (IPO)	OTTOBOCK	GERMANY	Implants & Prosthetics
09/2025	CREDIT MUTUEL EQUITY / EURAZEO / BPIFRANCE / BNP PARIBAS DEVELOPPEMENT	PROTEOR	FRANCE	Implants & Prosthetics
09/2025	CAPVEST PARTNERS	STADA	GERMANY	Generics / Labs
09/2025	INVESTCorporate	DCC HEALTHCARE	UNITED KINGDOM	CDMO
08/2025	LGT CAPITAL PARTNERS	NEMERA	FRANCE	Medical Consumables

REFERENCES

Valuation range: EV 100M - 350M EUR

Revenue range: 25M - 50M EUR

EBITDA range: 5M - 25M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of WINBACK by CHARTERHOUSE are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Acquirer: charterhouse